Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBCBS Nebraska basivertebral nerve ablation Prior A…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - NebraskaPolicy M.50

    Intraosseous Radiofrequency Ablation of the Basivertebral Nerve for Chronic Low Back Pain (Preauthorization Required)

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Nebraska Policy M.50 alerts

    Get alerted when Policy M.50 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines clinical coverage, criteria, contraindications, and coding for intraosseous radiofrequency ablation of the basivertebral nerve for vertebrogenic chronic low back pain (L3–S1) and requires preauthorization.

    Policy Summary
    PayerBlue Cross Blue Shield - Nebraska
    PolicyIntraosseous Radiofrequency Ablation of the Basivertebral Nerve for Chronic Low Back Pain (Preauthorization Required)
    Policy CodePolicy M.50
    Change TypeAnnual review — no material changes
    Effective DateMay 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateNov 4, 2026
    Key ActionObtain preauthorization and include documentation of age (>18), chronic LBP ≥6 months, ≥6 weeks PT, ≥6 months pharmacotherapy, and MRI showing Modic type 1 or 2 at L3–S1.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    L3–S1vertebral levels addressed
    >=6 mochronic LBP duration
    >=6 wkphysical therapy required
    64628/64629

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CPT codes listed
    Age>18minimum age
    ©2026copyright year

    Coverage Criteria for Basivertebral Nerve Ablation

    inv-01: Reasonable and necessary criteria (Initial therapy)

    Covered when ALL of the following are met

    BVN ablation coverage criteria: A. Skeletally mature patients (age >18 years) AND B. Chronic low back pain for at least 6 months AND C. Conservative measures tried and failed: (1) at least 6 weeks of documented physical therapy AND (2) at least 6 months of pharmacotherapy (narcotics, non-narcotic analgesics, muscle relaxants, neuroleptics, and/or anti-inflammatories) AND D. MRI demonstrates Type 1 or Type 2 Modic changes at one or more vertebrae from L3 to S1 AND E. Activities of daily living limited due to persistent low back painall

    inv-02: Not reasonable and necessary / Other indications

    Not reasonable and necessary when:

    Other uses: All other uses of intraosseous radiofrequency ablation (outside the specified indications/criteria) are considered not reasonable and necessary because effectiveness has not been establishedany

    Contraindications to intraosseous radiofrequency ablation of the basivertebral nerve include: skeletally immature patients (age <18 years); severe cardiac or pulmonary compromise; radicular pain; when the targeted ablation zone is <10 mm from a sensitive structure (including the vertebral foramen); active systemic or local infection at the treatment site; pregnancy; and presence of implantable pulse generators or other electronic implants.

    This policy defines clinical coverage and specific preauthorization requirements for intraosseous radiofrequency ablation of the basivertebral nerve (L3–S1). Preauthorization is required and benefit determination is dependent on the member’s applicable benefit contract; these Medical Policies do not constitute authorization, certification, or a contract for benefits.

    Any application of intraosseous radiofrequency ablation that does not meet all of the criteria listed in this policy (including age >18 years, chronic low back pain ≥6 months, required conservative therapy, MRI demonstrating Modic Type 1 or 2 changes at L3–S1, and limitation of activities of daily living) is considered not reasonable and necessary and therefore not covered.

    Coding and Related Criteria

    Other/UnlistedCPT
    22899UNLISTED PROCEDURE SPINE
    Covered CPT CodesCPTCovered
    64628THERMAL DSTRJ INTRAOSSEOUS BVN 1ST 2 LMBR/SAC - Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral
    64629THERMAL DSTRJ INTRAOSSEOUS BVN EA ADDL LMBR/SAC - Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; each additional vertebral body, lumbar or sacral (List separately in addition to code for primary procedure)
    Affected CPT codes (generic mention)CPT
    affected codesCPT codes referenced generically by the policy; specific CPT codes are not listed in these chunks.
    inv-09: Duration of chronic low back pain — key value
    Required duration of chronic low back pain>= 6 months
    Patient age requirementSkeletally mature (age >18 years)
    Anatomic levels specifiedModic changes at one or more vertebrae from L3 to S1
    inv-10: Duration of physical therapy — key value
    Required duration of documented physical therapy>= 6 weeks
    PurposePhysical therapy must be tried and failed as part of conservative measures prior to approval

    Provider Actions, Authorization & Documentation

    Prior Authorization

    Preauthorization required — BVN ablation

    Preauthorization is required for intraosseous radiofrequency ablation of the basivertebral nerve; the procedure (CPT 64628/64629 or unlisted 22899) is considered reasonable and necessary only when the policy's coverage criteria are fully met.

    • Procedure codes referenced: CPT 64628, 64629, or unlisted 22899.
    Prior Authorization

    Preauthorization process — follow BCBSN procedures

    Obtain preauthorization according to BCBS of Nebraska procedures before scheduling the intraosseous radiofrequency ablation; authorization should document that all policy criteria are satisfied.

    • Preauthorization must be requested through BCBSN preauthorization channels.
    • Ensure the request demonstrates that the patient meets all coverage criteria.

    Required Conservative Treatments Prior to Approval

    inv-24: Must be documented prior to approval — >= 6 weeks PT; >= 6 months pharmacotherapy

    Must be documented prior to approval

    Conservative therapy prerequisites: At least 6 weeks of documented physical therapy AND at least 6 months of pharmacotherapy (including narcotics, non-narcotic analgesics, muscle relaxants, neuroleptics, and/or anti-inflammatories) must have been tried and failedall

    Documentation should be included with preauthorization request

    Imaging Requirements

    Documentation Required

    MRI with Modic Type 1 or 2 required

    For BVN ablation, MRI must demonstrate Modic Type 1 or Type 2 changes at one or more vertebrae from L3 to S1; this imaging finding is required for coverage consideration.

    • Ensure MRI report documents Modic Type 1 or Type 2 changes at involved vertebral levels (L3–S1).

    Definitions and Key Terms

    inv-21: Modic changes (Type 1 and Type 2) — definition/key features
    Modic Type 1Vascular development in vertebral body with inflammation and edema, vertebral endplate changes, vascularized fibrous tissues within adjacent marrow, hypointensive signals on MRI
    Modic Type 2Replacement of normal bone marrow by fat in the vertebral body with hyperintensive signals on MRI
    Use in diagnosisModic changes are MRI findings in vertebral endplates used to support diagnosis of vertebrogenic pain
    inv-22: Vertebrogenic pain — definition
    DefinitionVertebrogenic pain: chronic low back pain resulting from vertebral endplate degeneration and pain from intraosseous (basivertebral) nerve signaling
    PathophysiologyDegeneration of vertebral endplates damages intraosseous nerves that traverse the vertebral bodies, producing chronic pain

    Background

    Intraosseous radiofrequency ablation of the basivertebral nerve is a minimally invasive, outpatient procedure intended to treat vertebrogenic chronic low back pain by thermally disrupting nociceptive signaling in the basivertebral nerve within the vertebral body. Diagnosis and patient selection rely on MRI evidence of vertebral endplate degeneration—specifically Modic Type 1 or Type 2 changes—at one or more levels from L3 through S1. The procedure is considered when conservative measures have failed (including at least 6 weeks of documented physical therapy and at least 6 months of pharmacotherapy) and the patient’s activities of daily living remain limited due to persistent low back pain.

    Not Covered Indications

    Use of intraosseous radiofrequency ablation for indications other than vertebrogenic chronic low back pain with MRI-confirmed Modic Type 1 or Type 2 changes at L3–S1 is considered not reasonable and necessary because effectiveness for other indications has not been established, and therefore such applications are not covered.

    Policy Summary
    PayerBlue Cross Blue Shield - Nebraska
    PolicyIntraosseous Radiofrequency Ablation of the Basivertebral Nerve for Chronic Low Back Pain (Preauthorization Required)
    Policy CodePolicy M.50
    Change TypeAnnual review — no material changes
    Effective DateMay 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateNov 4, 2026
    Key ActionObtain preauthorization and include documentation of age (>18), chronic LBP ≥6 months, ≥6 weeks PT, ≥6 months pharmacotherapy, and MRI showing Modic type 1 or 2 at L3–S1.
    SourceLink
    On This Page
    Coverage Criteria for Basivertebral Nerve AblationCoding and Related CriteriaProvider Actions, Authorization & DocumentationRequired Conservative Treatments Prior to ApprovalImaging RequirementsDefinitions and Key TermsBackgroundNot Covered Indications
    DocumentationAt least 6 weeks must be documented in preauthorization package
    inv-11: Duration of pharmacotherapy — key value
    Required duration of pharmacotherapy>= 6 months
    Included medication classesNarcotics, non-narcotic analgesics, muscle relaxants, neuroleptics, and/or anti-inflammatories
    RolePharmacotherapy must be tried and failed as part of conservative measures prior to approval
    Step Therapy

    Conservative therapy prerequisites

    Conservative therapies must be tried and failed prior to approval: at least 6 weeks of documented physical therapy and at least 6 months of pharmacotherapy.

    • Physical therapy: ≥ 6 weeks documented.
    • Pharmacotherapy: ≥ 6 months (narcotics, non‑narcotic analgesics, muscle relaxants, neuroleptics, and/or anti‑inflammatories).
    Note
    Documentation Required

    Required documentation for preauthorization

    Include the following documentation with the preauthorization request: confirmation of skeletal maturity (age >18), duration of chronic low back pain (≥6 months), documentation of failed conservative therapy (≥6 weeks PT and ≥6 months pharmacotherapy), MRI showing Modic Type 1 or 2 changes at one or more vertebrae from L3 to S1, and the procedure code pairing (CPT 64628/64629 or 22899 as applicable).

    • Patient age: >18 years.
    • Chronic low back pain duration: ≥6 months.
    • Physical therapy: ≥6 weeks documented.
    • Pharmacotherapy: ≥6 months documented.
    • MRI: Modic Type 1 or 2 at L3–S1.
    • Procedure coding: CPT 64628/64629 or 22899 (unlisted spine) as appropriate.
    Note

    Verify plan‑specific benefit terms and follow plan rules

    Follow plan‑specific benefit contract terms and BCBSN preauthorization procedures when requesting coverage; Medical Policies are used in administering plan benefits but do not replace benefit contract rules.

    • Verify member benefit coverage and applicable contract terms before seeking authorization.
    Denial Risk

    Denial triggers if coverage criteria not met

    Requests will be denied if the patient does not meet all coverage criteria (e.g., age >18, chronic LBP ≥6 months, required conservative therapy, MRI demonstrating Modic Type 1 or 2 at L3–S1, and ADL limitation) or if the indication is outside the specified L3–S1 vertebral levels.

    • Denial triggers include failure to document required conservative therapy, inadequate duration of pain, absence of Modic changes at L3–S1, or indications outside the policy's stated uses.
    Note

    Benefits determined by applicable benefit contract

    Benefits for a specific service or item are determined by the terms and conditions of the member's applicable benefit contract; Medical Policies do not constitute authorization, certification, or a contract for benefits.

    • Even if policy criteria are met, coverage depends on the member's benefit plan provisions.
    Device-specific noteIntracept® and OptaBlate BVN are approved for treatment of basivertebral nerve pain
    inv-23: 2019 Truumees et al. study — referenced clinical study note
    Study typeProspective, open-label, single-arm, multi-center study
    InterventionIntraosseous basivertebral nerve ablation
    Publication detailsTruumees E, Macadaeg K, et al. 2019; reported in 2019; pages 1594-1602